Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.79
Delayed Data
As of Mar 27
 +0.08 / +1.40%
Today’s Change
3.10
Today|||52-Week Range
7.84
-23.41%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 9.00. The median estimate represents a +72.71% increase from the last price of 5.79.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$3.6M
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
 
 
 
 
 
 
Growthannually -816.67%
 
 
 
 
 
 

Sales

Growthquarterly 730.30%
 
 
 
 
 
 
Growthannually -41.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account